MedPath

Effect of Wholegrain Wheat on Body Weight and Composition and Cardiovascular Risk

Not Applicable
Completed
Conditions
Obesity
Interventions
Other: wholegrain
Other: refined wheat
Registration Number
NCT00869531
Lead Sponsor
University of Copenhagen
Brief Summary

The aim of this study is to investigate the potential beneficial effect of wholegrain on body weight and composition as well as cardiovascular risk in overweight women.

Detailed Description

Objective: To study the effect of the 'wholegrain concept', i.e. high intake of wheat wholegrain (WW) vs. refined wheat (RW) grain products on body weight and composition.

Design: In this open-labeled randomized trial, 72 postmenopausal women with metabolic syndrome features were prescribed a mild calorie-restricted diet with a deficit of \~1,250kJ/d. Following 2 weeks run-in period on RW products, they were randomized to 12 weeks intervention with RW or WW products providing 2,000kJ/d.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
85
Inclusion Criteria
  • BMI 27-37
  • Postmenopausal (>1y) women
  • 40-70 years old
Exclusion Criteria
  • Medication (hypertensive treatment not included)
  • BP > 160/100
  • Fasting glucose > 7mM
  • Fasting cholesterol > 6.5mM
  • Smoking
  • Known chronic illnesses

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
WWwholegrainwholegrain wheat
RWrefined wheatrefined wheat
Primary Outcome Measures
NameTimeMethod
Body weight and composition0, 6 and 12 wks
Secondary Outcome Measures
NameTimeMethod
Cardiovascular risk markers0, 6 and 12 wks
Fecal parameters0 and 12 wks

Trial Locations

Locations (1)

University of Copenhagen, Department og Human Nutrition

🇩🇰

Frederiksberg C, Denmark

© Copyright 2025. All Rights Reserved by MedPath